General chapter Reimbursement of Specialty Drugs in the Hospital Inpatient Setting: Are current pathways in the USA and Europe sufficient? Stephen Hull & Claire Bezdek Gochal, Hull Associates LLC 1 Country chapters Angola Paulo Pinheiro, Francisca Paulouro & Pedro Fontes, Vieira de Almeida 16 Australia Greg Williams, Colin Loveday & Sheena McKie, Clayton Utz 23 Austria Francine Brogyanyi & Bernhard Muller, DORDA Rechtsanwalte GmbH 36 Belgium Pieter Wyckmans & Julie De Keukeleire, Quinz 48 Brazil Rodrigo Augusto Oliveira Rocci, Dannemann Siemsen Advogados 61 Canada Sara Zborovski, Christopher A. Guerreiro & Ian Trimble, Norton Rose Fulbright Canada LLP 73 China Nicolas Zhu, CMS China 80 France Catherine Mateu, Armengaud Guerlain 87 Germany Dr. Ulrich Reese & Carolin Kemmner, Clifford Chance LLP 100 India Archana Sahadeva, Deepshikha Malhotra & Bitika Sharma, Singh and Singh Law Firm LLP 112 Ireland Marie Doyle-Rossi & Maree Gallagher, Covington & Burling LLP 122 Japan Chie Kasahara, Yuji Tomioka & Kirika Morita, Atsumi & Sakai 131 Mozambique Paulo Pinheiro, Francisca Paulouro & Pedro Fontes, Vieira de Almeida 138 Norway Sigrid Toft Floystad & Per Thomas Thomassen, Advokatfirmaet Grette AS 144 Poland Agata Zalewska-Gawrych & Marta Skomorowska, Food & Pharma Legal Wawrzyniak Zalewska Radcy Prawni sp.j. 154 Portugal Paulo Pinheiro, Francisca Paulouro & Pedro Fontes, Vieira de Almeida 159 Romania Silvia Sandu, Bohalteanu si Asociatii 170 Spain Jordi Faus & Merce Maresma, Faus & Moliner 180 Sweden Odd Swarting & Camilla Appelgren, Calissendorff Swarting Advokatbyra KB 192 Switzerland Dr. Oliver Kunzler, Dr. Carlo Conti & Dr. Martina Braun, Wenger Plattner 202 United Kingdom Grant Castle & Brian Kelly, Covington & Burling LLP 210 USA Edward J. Dougherty, Dentons US LLP 220